Episode 550: SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status

POEM of the Week Podcast - A podcast by Mark Ebell and Michael Wilkes

Categories:

Science & Medicine

Dr. Ebell and Dr. Wilkes discuss the POEM titled ' SGLT2 inhibitors ("-flozin" meds) improve all-cause and CV mortality in patients regardless of diabetes or HF status '